deanol has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubois, B; Kanony-Truc, C; Murphy, MF; Pujadas-Navinés, F; Rainer, M; Riordan, HJ; Robert, P; Soininen, H; Touchon, J; Vellas, B; Zaim, M | 1 |
| Fisman, M; Helmes, E; Mersky, H | 1 |
2 trial(s) available for deanol and Alzheimer Disease
| Article | Year |
|---|---|
Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Antipsychotic Agents; Cholinergic Agents; Deanol; Double-Blind Method; Female; Glutamates; Humans; International Cooperation; Male; Middle Aged; Psychiatric Status Rating Scales; Retrospective Studies; Treatment Outcome | 2012 |
Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Confusion; Deanol; Dementia; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Male; Placebos; Psychomotor Disorders; Sleep Stages; Sleep Wake Disorders | 1981 |